Vision Fund investment portfolio company InterVenn's logo

InterVenn is leveraging an AI-powered clinical technology for glycoproteomics to transform healthcare.

Leadership
Joshua Stahl
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas